Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
NovImmune
company
About
NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
- 101 - 250
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $14M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 1998
- Number Of Employee
- 101 - 250
- Operating Status
- Active
NovImmmune is committed to innovation by discovering and developing therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$114.80M
NovImmune has raised a total of
$114.80M
in funding over 2 rounds. Their latest funding was raised on
May 12, 2009 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 12, 2009 | Series Unknown | $54.80M | 3 | — | — | Detail |
| Jun 1, 2006 | Series B | $46M | 1 | — | — | Detail |
| May 1, 2000 | Series A | $14M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
NovImmune is funded by 3 investors.
LODH Immunology Fund
and Ingro Finanz AG
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
|
|
— | Series Unknown |
Varuma
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
